WhaleCreepWhat the best hedge funds own, from their SEC 13F filings
HomeFundsValueAct Capital › Q1 2010

ValueAct Capital 13F holdings, Q1 2010

Holdings as of March 31, 2010 · filings on SEC EDGAR · latest filing →

ValueAct Capital disclosed 13 US equity positions worth $2.7bn in its Q1 2010 13F filing. The largest position was VALEANT PHARMACEUTICALS INTL at 28.5% of the reported book, followed by SARA LEE CORP and IT. Against the Q4 2009 filing, it opened 1 new position, added to 4 and reduced 3 among the top 13 holdings.

← Q4 2009 · Q2 2010 →

What did ValueAct Capital own in Q1 2010? Top 13 positions

#StockSectorWeightValueSharesΔ sharesvs Q4 2009
1 VALEANT PHARMACEUTICALS INTL 28.5%$762.8m17,775,903 0% held
2 SARA LEE CORP 18.2%$486.4m34,918,822 0% held
3 IT GARTNER GROUP INC NEW-CL A Technology 17.3%$462.4m20,790,013 0% held
4 C R BARD INC 8.7%$233.9m2,700,700 3% added
5 VRSN VERISIGN INC Technology 7.0%$188.6m7,250,000 99% added
6 WILLIS GROUP HOLDINGS LTD 7.0%$187.4m5,990,410 0% held
7 IMMUCOR INC 4.1%$109.3m4,882,779 10% added
8 MDS INC 2.9%$78.9m9,733,700 -58% reduced
9 SNA SNAP ON TOOLS CORP Industrials 2.8%$75.8m1,749,009 48% added
10 OPLN KAR AUCTION SERVICES INC Consumer Cyclical 1.3%$34.0m2,258,828 0% held
11 BFH ALLIANCE DATA SYSTEM CORP Financial Services 1.2%$32.0m500,000 -81% reduced
12 MYGN MYRIAD GENETICS INC Healthcare 0.6%$15.0m622,000 new
13 WARNER CHILCOTT PLC 0.4%$10.2m400,000 -77% reduced

Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.